DISCOUNT ZERTIFIKAT - NOVO NORDISK ADR B Share Price

Certificat

DE000MG1C9Q0

Real-time Bid/Ask 16:43:59 03/07/2024 BST
62.5 EUR / 62.53 EUR -0.71% Intraday chart for DISCOUNT ZERTIFIKAT - NOVO NORDISK ADR B
Current month-0.06%
1 month+1.65%
Date Price Change
03/07/24 62.7 -0.41%
02/07/24 62.96 -0.08%
01/07/24 63.01 +0.02%
28/06/24 63 -0.14%
27/06/24 63.09 -0.19%

Delayed Quote Börse Stuttgart

Last update July 03, 2024 at 11:36 am

More quotes

Static data

Product typeCertificats Discount
Buy / SellCALL
Underlying NOVO NORDISK A/S
Issuer Morgan Stanley
WKN MG1C9Q
ISINDE000MG1C9Q0
Date issued 02/04/2024
Cap 70 $
Last trading day 21/03/2025
Maturity 21/03/2025 (261 Days)
Parity 1 : 1
Emission price 62.06
Emission volume N/A
Payment day 28/03/2025
Bonus-
Settlement règlement en espèces
Currency EUR

Technical Indicators

Discount (ask) 50.82 %
Sideways yield 3.674 %
Sideways yield pa 5.138 %
Outperformance point 142.3 $
Break even 67.30 €
Highest since issue 63.21
Lowest since issue 60.81
Spread 0.02
Spread %0.03%
Distance Cap 67.9 $
Distance Cap %+49.24%
Max. earning 2.297
Max. earning % 3.674 %

Company Profile

Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows: - diabetes and obesity treatment products (92.6%); - rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Sector
-
More about the company

Ratings for Novo Nordisk A/S

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Consensus: Novo Nordisk A/S

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
993.5 DKK
Average target price
952.2 DKK
Spread / Average Target
-4.16%
Consensus